Status:

TERMINATED

A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)

Lead Sponsor:

Merck Sharp & Dohme LLC

Conditions:

Neoplasms

Solid Tumors

Eligibility:

All Genders

Up to 21 years

Phase:

PHASE1

Brief Summary

This is a Phase 1/1B, non-randomized, open-label, dose-escalation study of robatumumab (SCH 717454, MK-7454) administered in combination with chemotherapy in pediatric participants with solid tumors, ...

Eligibility Criteria

Inclusion

  • Must be \<= 21 years of age (older participants may be allowed on study on a case-by-case basis); may be of either sex, and of any race/ethnicity.
  • Must have histologic confirmation of the advanced solid tumor, except for brainstem tumors.
  • Must have Karnofsky performance score of \>=50 (if participant is \>16 years of age) or a Lansky score of \>50 (if participant is \<=16 years of age).
  • Must have adequate organ function during Screening.
  • Must be able to adhere to dose and visit schedules.

Exclusion

  • Must not have a history of another malignancy.
  • Must not have uncontrolled diabetes mellitus.
  • Must not have persistent, unresolved common terminology criteria for adverse events (CTCAE) Grade \>=2 drug-related toxicity associated with previous treatment.
  • Must not have known hypersensitivity to other antibodies, or any accompanying excipients associated with these medications.
  • If female, must not be breast-feeding, pregnant, intending to become pregnant, or have a positive pregnancy test at Screening.
  • Must not be known to have human immunodeficiency virus (HIV) infection or known HIV-related malignancy.
  • Must not be known to have active Hepatitis B, or Hepatitis C.
  • Must not have any serious or uncontrolled infection.

Key Trial Info

Start Date :

November 11 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 22 2010

Estimated Enrollment :

4 Patients enrolled

Trial Details

Trial ID

NCT00960063

Start Date

November 11 2009

End Date

December 22 2010

Last Update

August 27 2018

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.